Fig. 1 · Structure
Documents & Downloads
DL-Laudanosine
Cat. No.
A70134
CAS
1699-51-0
Drug Metabolite
DL-Laudanosine, a metabolite of Atracurium and Cisatracurium, acts on the central nervous system by crossing the blood-brain barrier. It is known to induce excitatory responses and has been linked to seizure activity. This compound is used in research related to neuromuscular blockade and CNS effects of anesthetic agents.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 1699-51-0 |
| Applications | Drug Metabolite |
| Formula | C21H27NO4 |
| Molecular Weight | 357.44 |
| SMILES | COC1=CC(CC2N(CCC3=C2C=C(C(OC)=C3)OC)C)=CC=C1OC |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.